Evidence map›Paper›PMID 32443939›Full record

ReviewASN neuro

Shedding Light on the Dark Side of the Microglia.

Marie-Kim St-Pierre, Eva Šimončičová, Eszter Bögi, Marie-Ève Tremblay

Open access · goldAbstract readReview
In one paragraph

Review in ASN neuro. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Role of NRF2 in Pathogenesis of Alzheimer's Disease.Antioxidants (Basel, Switzerland) · 2024
    Review
  9. Article
  10. Review
  11. Review
  12. Inflammaging and Brain Aging.International journal of molecular sciences · 2024
    Review
  13. Review
  14. General Pathophysiology of Microglia.Advances in neurobiology · 2024
    Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Marie-Kim St-PierreAxe Neurosciences, Centre de Recherche du CHU de Québec-Université Laval.
Eva ŠimončičováAxe Neurosciences, Centre de Recherche du CHU de Québec-Université Laval.
Eszter BögiDepartment of Pharmacology, Jessenius Faculty of Medicine, Comenius University, Martin, Slovak Republic.
Marie-Ève TremblayAxe Neurosciences, Centre de Recherche du CHU de Québec-Université Laval.ORCID 0000-0003-2863-9626
Université Laval · CAComenius University Bratislava · SKSlovak Academy of Sciences · SK

Funding

CIHR
6 · The paper itself

Abstract

Microglia, the resident immune cells of the central nervous system, are not a homogeneous population; their morphology, molecular profile, and even their ultrastructure greatly vary from one cell to another. Recent advances in the field of neuroimmunology have helped to demystify the enigma that currently surrounds microglial heterogeneity. Indeed, numerous microglial subtypes have been discovered such as the disease-associated microglia, neurodegenerative phenotype, and Cd11c-positive developmental population. Another subtype is the dark microglia (DM), a population defined by its ultrastructural changes associated with cellular stress. Since their first characterization using transmission electron microscopy, they have been identified in numerous disease conditions, from mouse models of Alzheimer's disease, schizophrenia, fractalkine signaling deficiency to chronic stress, just to name a few. A recent study also identified the presence of cells with a similar ultrastructure to the DM in

Indexed as

AnimalsBrainChemokine CX3CL1HumansMental DisordersMicrogliaMicroscopy, Electron, TransmissionNeurodevelopmental DisordersChemokine CX3CL1dark microgliaelectron microscopy, mouse models, human brain samplesheterogeneitynonhomeostatic conditionspostnatal development

Identifiers

PMID32443939
PMCPMC7249604
OpenAlexW3027350326

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.